An overview of experience with taxol∗ (paclitaxel) in the U.S.A
- 1 October 1993
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 19, 63-78
- https://doi.org/10.1016/0305-7372(93)90049-w
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Phase II Study of Taxol, Merbarone, and Piroxantrone in Stage IV Non-Small-Cell Lung Cancer: The Eastern Cooperative Oncology Group ResultsJNCI Journal of the National Cancer Institute, 1993
- Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast CancerJNCI Journal of the National Cancer Institute, 1991
- Demonstration of the cell cycle positions of taxol-induced "asters" and "bundles" by sequential measurements of tubulin immunofluorescence, DNA content, and autoradiographic labeling of taxol-sensitive and -resistant cells.Journal of Histochemistry & Cytochemistry, 1989
- Taxol: an antimitotic agent with a new mechanism of actionPharmacology & Therapeutics, 1984
- Nerve Growth Factor Attenuates Neurotoxic Effects of Taxol on Spinal Cord-Ganglion Explants from Fetal MiceScience, 1982
- Structure-activity study of cytotoxicity and microtubule assembly in vitro by taxol and related taxanesBiochemical and Biophysical Research Communications, 1982
- Promotion of microtubule assembly in vitro by taxolNature, 1979
- ADVERSE REACTIONS TO INTRAVASCULARLY ADMINISTERED CONTRAST MEDIAAmerican Journal of Roentgenology, 1975
- The administration of radiographic contrast media to patients with a history of a previous reactionJournal of Allergy and Clinical Immunology, 1975
- Plant antitumor agents. VI. Isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifoliaJournal of the American Chemical Society, 1971